NeurAxis Information

NeurAxis, Inc. (NYSE American: NRXS) is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis is dedicated to advancing science and leveraging evidence-based medicine to drive adoption of IB-Stim®, its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology — a clinically proven, drug free option for functional abdominal pain. IB-Stim is FDA-cleared for functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD), and FD-related nausea symptoms in patients 8 years and older. Important information for IB-Stim: ibstim.com/important-information. NeurAxis also manufactures RED™ (Rectal Expulsion Device), an FDA-cleared, point-of-care test used by trained health care professionals to evaluate pelvic floor dysfunction and rectal hypersensitivity in adults with chronic constipation. Important information for RED: https://red4constipation.com/information/ Headquartered in Carmel, Indiana. Learn more at neuraxis.com